Autoimmune disorders encompass a wide range of immunological diseases that affect 4 to 10% of the population worldwide. They occur when immunological tolerance toward self-antigens is broken, resulting in immune responses against cells, tissues, or organs that lead to tissue dysfunction and/or destruction. The goal of autoimmune disease therapy is to restore tolerance to the self-antigen that causes the pathology by targeting autoreactive T cells while preserving immune competence to prevent infections and malignancies. The main challenge of this endeavor resides in choosing the mode by which the disease-driving antigen is delivered so that it can initiate the removal or reprogramming of the autoreactive T cells or the induction and/or expansion of antigen-specific regulatory T (Treg) cells to suppress autoreactive T cells. Although the potential of antigenbased immunotherapy approaches to restore tolerance have been demonstrated for the treatment of immunoglobulin E (IgE) – mediated peanut allergy (1), antigen therapies for autoimmune disorders are still being developed.
Browsing: treatment
Prisoners Rehabilitation and Welfare Action (PRAWA), a non-governmental organization , has called for an end to the degrading treatment meted out to prisoners and ex-prisoners across the country and globally.
A molecular biologist, Dr Bamidele Iwalokun, has advised Nigerians to urgently treat malaria attacks to prevent shortage of blood, cerebral…
AstraZeneca says the European Commission has approved its prescription medicine Saphnelo as an add-on therapy for the treatment of adult…
The UN Children’s Fund (UNICEF) on Friday warned that no fewer than 1.5 million children were not receiving life-saving treatment…
Uche Edochie, son of Veteran Nollywood actor, Pete Edochie has said that he spent over N6 million to treat COVID-19 …
The Joint United Nations Programme on HIV/AIDS (UNAIDS) has said that almost half of the world’s 1.7 million children living…
South Korea’s drug safety agency said Friday it has approved pharmaceutical giant Celltrion Inc.’s COVID-19 treatment candidate on several conditions.…
By Erin Garcia de Jesus In the four days since revealing he had COVID-19, President Donald Trump has been treated with…
By Harvey A. Risch, MD, PHD As a professor of epidemiology at Yale School of Public Health, I have authored…